- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.09. | European big pharma unites amid 'ringing alarm bells' of continent's dominance | ||
| 23.09. | Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal | ||
| 23.09. | BoomRay and Novartis Pharma sign $900m deal for radioligand therapy | ||
| 23.09. | Boehringer and Envisagenics to develop precision cancer therapies | ||
| 22.09. | Novo targets blockbuster-heavy 2030 but share slump signals unease | ||
| 22.09. | Made Scientific acquires cell therapy facility in Pennsylvania, US | ||
| 22.09. | EC approves Menarini and NewAmsterdam's obicetrapib therapies | ||
| 21.09. | Beijing unveils blueprint for biomedical dominance by 2030 | ||
| 21.09. | Telix to acquire ITM in deal worth up to $2.35bn | ||
| 21.09. | Sandoz and mAbxience agree on emicizumab biosimilar partnership | ||
| 18.09. | FDA approves first gene therapy for Sanfilippo syndrome type A | ||
| 18.09. | Novo targets oral macrocycles with $1.4bn Orbis partnership | ||
| 18.09. | Ona Therapeutics to develop ADC with WuXi's payload-linker platform | ||
| 18.09. | Roche agrees $1bn deal with Dualitas for bispecific antibody research | ||
| 17.09. | Novo taps Anthropic's Claude to 'supercharge' R&D efforts | ||
| 17.09. | Cellares and GenomeFrontier to assess automated GF-CART01 production | ||
| 17.09. | Viatris' Wakix receives Japanese approval to treat OSAS and narcolepsy | ||
| 16.09. | Sling ropes in $123m for oral thyroid eye disease drug | ||
| 16.09. | Gilead and PAHO agree to expedite lenacapavir access for HIV prevention | ||
| 16.09. | Eli Lilly and QurCan sign genetic medicine deal | ||
| 15.09. | Electra Therapeutics targets $342m IPO to fund hyperinflammatory syndrome drug's pivotal trials | ||
| 15.09. | Agentic AI trust gap slowing healthcare provider adoption, survey reveals | ||
| 15.09. | GSK bolsters oncology pipeline with $750m Chimagen TCE deal | ||
| 15.09. | Definium tees up regulatory submission for psychedelic on Phase III hat trick | ||
| 15.09. | Cheplapharm to take over 20 medicines and three sites from Sanofi |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.